Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells. Journal title: Pharmacological Reports Authors: Mariola Dorecka, Krzysztof Siemianowicz, Tomasz Francuz, Wojciech Garczorz, Agnieszka Chyra, Wanda R... Subject(s):
AN OBSERVATIONAL STUDY COMPARING SITAGLIPTIN TO METFORMIN AS A INITIAL MONOTHERAPY IN TYPE 2 DIABETES MELLITUS PATIENTS Journal title: Journal of Evolution of Medical and Dental Sciences Authors: Mohd Riyaz, Imran , Rinu Manuel, Nidhisha Joseph Subject(s):
THERAPY WITH GLP-1 AGONISTS AND DIPEPTIDYL-PEPTIDASE IV INHIBITORS IN TYPE 2 DIABETES MELLITUS Journal title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases Authors: Nikos Rigas, Floriana Elvira Ionica, Florica Popescu Subject(s):
TREATMENT OF OBESITY: NEWER PERSPECTIVES Journal title: Journal of Evolution of Medical and Dental Sciences Authors: Abhyuday Verma, Deepika Verma Subject(s):
Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy Journal title: Міжнародний ендокринологічний журнал Authors: V.L. Orlenko, K.P. Zak Subject(s):
TCF7L2 gene variant rs7903146 affects the risk of Type 2 Diabetes by modulating incretin secretion Journal title: International Archives of Integrated Medicine Authors: Shanmugapriya Chandrasekaran, Poonguzhali Gopinath Subject(s):
